Welcome To b2b168.com, Join Free | Sign In
中文(简体) |
中文(繁體) |
Francés |Español |Deutsch |Pусский |
| No.3094924
![](http://i.b2b168.com/e/tag_pthy.gif)
- Product Categories
- Friendly Links
Information Name: | Hydroxyethyl starch 130/0.4 and 200/0.5 supply of raw materials, fluid 6 +6 |
Published: | 2008-11-26 |
Validity: | 600 |
Specifications: | |
Quantity: | 0.00 |
Price Description: | |
Detailed Product Description: | Hydroxyethyl starch 130/0.4 and 200/0.5 raw materials, the amount of fluid 6 +6 is the best generation of clinical plasma products. Market is large, effective, profitable! A real large-scale production process, can be synthesized reference standards of different molecular weight and low cost. Process to ensure that the true cost. Production to be reported A flutter amoxicillin powder for injection of raw materials and their broad-spectrum antibiotics penicillin 3.1, respiratory, gastrointestinal, gallbladder, urinary, bone and soft tissue and reproductive organs such as infections, gynecology infections, otitis externa, burns, skin and surgical infections. Is not yet declared to be completed clinical report Raw materials and powder for injection 3.1 for Mo Xilin orphan drug indications, the strongest effect on the G-bacteria, and third-generation cephalosporins do not cross-resistant to be reported complete clinical 3 for sperm injection of glutamate by acute and chronic liver disease such as cirrhosis, fatty liver, hepatitis caused by hyperammonemia, especially in liver disease due to central nervous system symptoms caused by the lifting of the rescue of hepatic coma. Approval documents to complete the clinical data to be reported Raw materials and injection naira Bin 3.1 for 1 to 21 years with refractory or relapsed acute lymphoblastic leukemia (ALL) patients. Can be reported clinical remission of clinical 3.3 rabeprazole sodium injection for bleeding or severe erosion of active duodenal ulcer and gastric ulcer. Approval documents to be reported complete clinical Ai dextrin test materials, peritoneal dialysis solution 3 (1) the world's first new isotonic dialysate, 1st generation to overcome the disadvantages of peritoneal dialysis fluid, long-term use will not cause glucose metabolism disorders, diabetes or impaired glucose tolerance for to reduce those. 36 countries reported clinical documents of approval to be listed Pula ibuprofen capsules three categories of raw materials and anti-inflammatory, analgesic: chronic rheumatoid arthritis, deformation of the joint disease, neck and shoulder Yao Tuiteng, gingivitis, gout attacks; acute upper respiratory tract inflammation, acute bronchitis; trauma, small surgery, such as completing the report after tooth extraction Clinical approval documents Orlistat capsules of raw materials + 3 + 6 in the world the only safe, non-central nervous system of weight loss drugs, significantly reduce weight, improve blood lipid, lower blood pressure can help obese patients with hypertension. Capsule 120mg * 21 capsules / box ¥ 196. To be reported The total volume cream compound 3 (2) compound, for pustules, eczema, scabies, folliculitis, skin lesions caused by trauma, can accelerate wound healing, inhibit bacterial infection and reduce scarring. Effect is remarkable! Completing the clinical report (Exclusive) Proparacaine raw materials, eye drops 3 +6 for a variety of eye surgery and eye examinations for topical anesthesia. No declaration 15ml/75mg, exclusive of production to be reported Fluticasone propionate material, cream, aerosol, nasal spray side effects of 6 is currently the strongest and the smallest of hormone drugs, respectively, for asthma, dermatitis, rhinitis embolism. To be reported Shandong Pharmaceutical Technology Development Co., Ltd. Cheng Chong Marketing Director: Chen Wei Tel: ,0531-897 |
Admin>>>
You are the 5399 visitor
Copyright © GuangDong ICP No. 10089450, Shandong Pharmaceutical Technology Development Co., Ltd. Cheng Chong All rights reserved.
Technical support: ShenZhen AllWays Technology Development Co., Ltd.
AllSources Network's Disclaimer: The legitimacy of the enterprise information does not undertake any guarantee responsibility
You are the 5399 visitor
Copyright © GuangDong ICP No. 10089450, Shandong Pharmaceutical Technology Development Co., Ltd. Cheng Chong All rights reserved.
Technical support: ShenZhen AllWays Technology Development Co., Ltd.
AllSources Network's Disclaimer: The legitimacy of the enterprise information does not undertake any guarantee responsibility